Browsing by Subject Friedreich ataxia
Showing results 10 to 18 of 18
< previous
Issue Date | Title | Author(s) |
---|---|---|
5-Jun-2020 | HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s Ataxia | Sherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condò, I; Malisan, F; Al-Mahdawi, S; Pook, M; Testi, R |
2010 | Investigating the pathogenesis and therapy of Friedreich Ataxia | Sandi, Chiranjeevi |
2012 | The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model | Ezzatizadeh, V; Pinto, RM; Sandi, C; Sandi, M; Al-Mahdawi, S; Te Riele, H; Pook, MA |
2013 | Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia | Li, L; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP |
2011 | Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model | Sandi, C; Pinto, RM; Al-Mahdawi, S; Ezzatizadeh, V; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pook, MA |
2007 | Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life | Pook, M A; De Biase, I; Ramussen, A; Monticelli, A; Al-Mahdawi, S; Cocozza, S; Bidichandani, S |